山东大学学报 (医学版) ›› 2023, Vol. 61 ›› Issue (6): 109-112.doi: 10.6040/j.issn.1671-7554.0.2022.1335
• 病例报道 • 上一篇
崔婷婷,王丽,许耀,王浩,徐兴晟,孟庆峰
中图分类号:
| [1] Kounis NG, Zavras GM. Histamine-induced coronary artery spasm: the concept of allergic angina[J]. Br J Clin Pract, 1991, 45(2): 121-128. [2] 张光明, 崔炜. Kounis综合征[J]. 临床心血管病杂志, 2017, 33(11): 1040-1044. ZHANG Guangming, CUI Wei. Progress in the kounis syndrome[J]. Journal of Clinical Cardiology, 2017, 33(11): 1040-1044. [3] 贠利新. Kounis综合征研究进展[J]. 吉林医学, 2020, 41(11): 2765-2767. YUN Lixin. Research progress of Kounis syndrome[J]. Jilin Medical Journal, 2020, 41(11): 2765-2767. [4] Lopez PR, Peiris AN. Kounis syndrome[J]. South Med J, 2010, 103(11): 1148-1155. [5] Kounis NG. Kounis syndrome: an update on epidemiology, pathogenesis, diagnosis and therapeutic management[J]. Clin Chem Lab Med, 2016, 54(10): 1545-1559. [6] Abdelghany M, Subedi R, Shah S, et al. Kounis syndrome: a review article on epidemiology, diagnostic findings, management and complications of allergic acute coronary syndrome[J]. Int J Cardiol, 2017, 232: 1-4. doi:10.1016/j.ijcard.2017.01.124. [7] Fassio F, Losappio L, Antolin-Amerigo D, et al. Kounis syndrome: a concise review with focus on management[J]. Eur J Intern Med, 2016, 30: 7-10. doi:10.1016/j.ejim.2015.12.004. [8] Akoz A, Tanboga HI, Emet M, et al. A prospective study of Kounis syndrome: clinical experience and cardiac magnetic resonance imaging findings for 21 patients[J]. Acta Med Mediterraea, 2013, 23(9): 811-816. [9] Alblaihed L, Huis In t Veld MA. Allergic acute coronary syndrome-kounis syndrome[J]. Emerg Med Clin North Am, 2022, 40(1): 69-78. [10] Kounis NG. Coronary hypersensitivity disorder: the kounis syndrome[J]. Clin Ther, 2013, 35(5): 563-571. [11] 李佳名, 刘俊兰, 陈侠, 等. Kounis综合征的诊治进展[J]. 临床心血管病杂志, 2019, 35(11): 1053-1056. LI Jiaming, LIU Junlan, CHEN Xia, et al. Advances in research on diagnosis and treatment of Kounis syndrome[J]. Journal of Clinical Cardiology, 2019, 35(11): 1053-1056. [12] Mastoris I, Flynn B. Kounis syndrome or allergic angina: an elusive entity[J]. J Cardiothorac Vasc Anesth, 2022, 36(7): 2077-2079. [13] Lovecchio F. Heparin-induced thrombocytopenia[J]. Clin Toxicol(Phila), 2014, 52(6): 579-583. [14] 中国医师协会心血管内科医师分会血栓防治专业委员会, 《中华医学杂志》编辑委员会. 肝素诱导的血小板减少症中国专家共识(2017)[J]. 中华医学杂志, 2018, 98(6): 408-417. [15] Hogan M, Berger JS. Heparin-induced thrombocytopenia(HIT): review of incidence, diagnosis, and management[J]. Vasc Med, 2020, 25(2): 160-173. [16] Zhou P, Yin JX, Tao HL, et al. Pathogenesis and management of heparin-induced thrombocytopenia and thrombosis[J]. Clin Chim Acta, 2020, 504: 73-80. doi:10.1016/j.cca.2020.02.002. [17] 张明, 刘德敏, 崔炜. 肝素诱导的血小板减少症治疗的研究进展[J]. 心血管病学进展, 2019, 40(9): 1219-1223. ZHANG Ming, LIU Demin, CUI Wei. Heparin-induced thrombocytopenia treatment[J]. Advances in Cardiovascular Diseases, 2019, 40(9): 1219-1223. [18] Hvas AM, Favaloro EJ, Hyh ellfritzsch M. Heparin-induced thrombocytopenia: pathophysiology, diagnosis and treatment[J]. Expert Rev Hematol, 2021, 14(4): 335-346. |
| [1] | 唐振旺. 不稳定型心绞痛介入治疗后基质金属蛋白酶9的表达改变对预后的影响[J]. 山东大学学报(医学版), 2012, 50(2): 120-. |
| [2] | 巩性军，吴树明，张供，李守先，庞昕焱. 无顶冠状静脉窦综合征的诊断和外科治疗[J]. 山东大学学报(医学版), 2209, 47(6): 129-. |
| [3] | 巩性军,张供,庞昕焱,李守先,谷兴华. 同种带瓣主动脉移植供体组织钙含量的定量分析[J]. 山东大学学报(医学版), 2008, 46(9): 842-846. |
| [4] | 巩性军，吴树明，张供，李守先，庞昕焱. 无顶冠状静脉窦综合征的诊断和外科治疗[J]. 山东大学学报(医学版), 2009, 47(6): 129-. |
|
||
